Senior Advisors

About Us

Thomas P. Monath, M.D.

Dr. Monath is a Partner, Pandemic and Biodefense Fund, at Kleiner Perkins Caufield & Byers. He is also Adjunct Professor, Harvard School of Public Health. Between 1992 and 2006, Dr. Monath was Chief Scientific Officer and an Executive Director at Acambis, plc where he directed R&D on dengue, West Nile, Japanese encephalitis, yellow fever, Clostridium difficile, and smallpox vaccines for defense against bioterrorism.

Dr. Monath retired from the US Army as a Colonel in 1992 after 24 years in the uniformed services. Between 1973 and 1988, he was Director, Division of Vector-Borne Viral Diseases, Centers for Disease Control, Fort Collins, Colorado, and from 1989-1992 he was Chief, Virology Division, US Army Medical Research Institute of Infectious Diseases (USAMRIID).

He has served on numerous government and international committees on infectious diseases, biosecurity, World Health Organization expert committees, and the National Vaccines Advisory Committee (USA).

Dr. Monath received his undergraduate degree from Harvard College and his MD from Harvard Medical School and trained in internal medicine at the Peter Bent Brigham Hospital, Boston. Dr. Monath is also Adjunct Professor, Harvard School of Public Health and on the editorial board of five scientific journals.

Christopher M. Cashman

David Hirsch, MD, PhD

Managing Director, Longitude Capital

 

 

 

Dr. Luc Marengère

Managing Partner, TVM Capital Life

P. Sherrill Neff

Founding Partner, Quaker Partners

Nat Ricciardi

Andrew Khouri

Director of Business Development and Strategy

Steven Raters

Vice President of Global Customer Service